Bile acids protect the liver against the cholestatic effect of large bilirubin loads

Scand J Gastroenterol. 1995 Dec;30(12):1186-93. doi: 10.3109/00365529509101629.

Abstract

Background: This study was undertaken to elucidate why large bilirubin loads cause canalicular cholestasis and whether bile acid infusions protect against bilirubin-induced cholestasis.

Methods: The effects of bilirubin infusion on canalicular bile secretion and canalicular membrane morphology were studied in bile acid-depleted pigs (BADP), bile acid-primed pigs (BAPP), and pigs co-infused with bile acids during bilirubin loading (BACIP).

Results: Bilirubin caused complete cholestasis in BADP, 38% bile flow reduction in BAPP, and no effect on bile flow in BACIP. Scanning electron micrographs showed loss of 70% of canalicular microvilli in BADP, 13% loss and pathologic changes in the remaining 75% of microvilli in BAPP, and no canalicular changes in BACIP. Cholestasis was not due to hydromechanical obstruction of bile ductules or bile Ca2+ depletion.

Conclusion: Bilirubin causes cholestasis in BADP by injuring canalicular microvilli. Intravenous glycocholate infusions fully protect the liver against bilirubin-induced cholestasis and canalicular microvillar injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bile Acids and Salts / therapeutic use*
  • Bile Canaliculi / pathology*
  • Cholestasis / drug therapy*
  • Cholestasis / etiology*
  • Cholestasis / pathology
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Female
  • Hyperbilirubinemia / complications*
  • Infusions, Intravenous
  • Male
  • Swine

Substances

  • Bile Acids and Salts